CompletedNot Applicable

Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome

Pakistan190 participantsStarted 2024-12-20

Plain-language summary

This study evaluates the effectiveness of high- and moderate-intensity statins in achieving target low-density lipoprotein cholesterol (LDL-C) levels in patients with acute coronary syndrome (ACS). The study aims to determine whether moderate-intensity statins can provide comparable benefits to high-intensity statins, particularly for patients at higher risk of adverse effects from higher doses. The findings may inform treatment decisions and reduce financial and clinical burdens on patients.

Who can participate

Age range25 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants aged between 25 and 85 years. * Both males and females. * Diagnosed with acute coronary syndrome as defined in the operational definitions. Exclusion Criteria: * History of adverse reactions to statins (e.g., hypersensitivity, myopathy, acute renal failure). * Current acute liver disease. * Pregnant or breastfeeding women. * Participants already on statin therapy

What they're measuring

Reduction in Low-Density Lipoprotein Cholesterol Level

Timeframe: 3 months after the start of treatment

Trial details

NCT IDNCT06782243

SponsorKhyber Medical University Peshawar

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-30

View on ClinicalTrials.gov More Acute Coronary Syndrome trials